Duke University recently received $10 million in science research funding from the National Institutes of Health to create an Antibacterial Resistance Leadership Group to conduct research lab investigations into the causes of antibacterial resistance. The new research grant was awarded in fiscal year 2014 to the department of internal medicine at Duke University Schools of Medicine and project leader Dr. Vance Fowler.
This most recent research grant follows a $2 million NIH award for similar studies awarded in June of 2013. Biotechnology Calendar, Inc. spotlighted this funding last summer on the Science Market Update blog and quoted NIAID Director Anthony S. Fauci, M.D. from an article on the NIH website:
“Antibacterial resistance is a serious and growing public health threat that is endangering the global medical community’s ability to effectively treat conditions ranging from simple skin infections to tuberculosis. Through this new clinical research network, we will strengthen our existing research capacity and address the most pressing scientific priorities related to antibacterial resistance.”
Image courtesy of Ildar Sagdejev and Wikimedia Commons
In an NIH project information report, Duke researchers said the Antibacterial Resistance Leadership Group would work with world-renowned science researchers to advance antibacterial resistance research and develop a network of investigators with common research lab goals.
“We will pair an unprecedented team of over two dozen of the world's top investigators with the organizational excellence of the Duke Clinical Research Institute (DCRI), one of the world's largest Academic Research Organizations. Because of the complexity of integrating multiple components of such a large-scale clinical research network, our submission features centralized leadership through an Executive Committee and a dual PI approach. One PI (Fowler) focuses primarily on operations and the other (Chambers) focuses largely on scientific agenda. The organizational structure, modeled after that of the ACTG, also features Scientific Subcommittees devoted to four priority areas: Gram-negative bacterial infections, Stewardship and infection prevention, Gram-positive bacterial infections, and Diagnostics and devices.”
Duke University receives a wealth of research funding from external funding organizations that rivals the budgets of top research institutions across the globe. Duke University’s endowment was worth $6 billion in 2013. That same year, the NIH awarded Duke University $350.2 million in science research funding and the NSF gave the university $44.6 million in research grants.
Lab suppliers marketing their life science products to research lab scientists in North Carolina will want to take note of the life science marketing opportunities available at Duke University. If you are a lab supplier interested in increasing your brand recognition and turning lab product leads into sales at well-established life science vendor shows, Biotechnology Calendar, Inc. invites you to attend our 15th Annual BioResearch Product Faire™ Event at Duke University on May 8th, 2014. Last year, this event attracted 314 attendees, of which 78 were purchasing agents, professors and post docs, and 56 were lab managers.
Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that organizes life science vendor shows at top research universities across the country. If you are interested in exhibiting at a life science vendor show closer to home, we encourage you to view our 2014 calendar of events. For more information on the BioResearch Product Faire™ Event at Duke University, or to learn more about funding statistics at Duke University, click on the button below.